Safety, Tolerability, and Activity of ALV003: Results from Two Phase 1 Single, Escalating-Dose Clinical Trials

Authors

Keywords

Journal

Volume 57, Issue 2, Pages 440-450

Publisher

Springer Nature

Online

2011-09-22

DOI

10.1007/s10620-011-1906-5

References

View 5 related references

Explore over 38,000 international journals covering a vast array of academic fields.

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started